Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder Diseases

Explore clinical trials studying Urinary Bladder Diseases. Study availability and eligibility vary by location and protocol.

2,289 public trials 413 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder Diseases trial results

Completed

An Effectiveness And Safety Study Of PD 0299685 For The Treatment Of Symptoms Associated With Interstitial Cystitis

NCT00739739

Conditions
Cystitis, Cystitis, Interstitial, Female Urogenital Diseases, +7 more
Locations
  • Pfizer Investigational Site Mobile, Alabama, United States
  • Pfizer Investigational Site Goodyear, Arizona, United States
  • Pfizer Investigational Site Litchfield Park, Arizona, United States
  • Pfizer Investigational Site Phoenix, Arizona, United States
View all 44 locations
View Trial Details
Completed

Study The Effects Of Different Doses Of UK-369,003 In Men With Overactive Bladder

NCT00479505

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +8 more
Locations
  • Pfizer Investigational Site Miranda, New South Wales, Australia
  • Pfizer Investigational Site Kippa-Ring, Queensland, Australia
  • Pfizer Investigational Site Victoria, British Columbia, Canada
  • Pfizer Investigational Site Barrie, Ontario, Canada
View all 52 locations
View Trial Details
Completed

Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine Extended Release(ER)in Patients With Overactive Bladder.

NCT00611026

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
Locations
  • Pfizer Investigational Site Enterprise, Alabama, United States
  • Pfizer Investigational Site Mobile, Alabama, United States
  • Pfizer Investigational Site Montgomery, Alabama, United States
  • Pfizer Investigational Site Chandler, Arizona, United States
View all 227 locations
View Trial Details
Completed

UK Study Assessing Flexible Dose Fesoterodine in Adults

NCT00806494

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +8 more
Locations
  • Pfizer Investigational Site Ely, Cambridgeshire, United Kingdom
  • Pfizer Investigational Site Crewe, Cheshire, United Kingdom
  • Pfizer Investigational Site Fowey, Cornwall, United Kingdom
  • Pfizer Investigational Site Penzance, Cornwall, United Kingdom
View all 39 locations
View Trial Details

Related conditions